» Articles » PMID: 18299469

Osteoprotegerin in Relation to Body Weight, Lipid Parameters Insulin Sensitivity, Adipocytokines, and C-reactive Protein in Obese and Non-obese Young Individuals: Results from Both Cross-sectional and Interventional Study

Overview
Specialty Endocrinology
Date 2008 Feb 27
PMID 18299469
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We analyzed the relation of osteoprotegerin (OPG) with insulin sensitivity, lipid profile, serum glutamic pyruvic transaminase (SGPT), adipocytokines, and C-reactive protein (CRP) in obese and non-obese subjects.

Methods: In the study, 170 subjects (106 obese and 64 non-obese, sex ratio female/male=2.03) were included. Thirty-two obese subjects were reevaluated 6 months after the weight loss induced by bariatric surgery.

Results: OPG did not differ between obese and non-obese subjects (respective mean values 5.17 and 4.96 pmol/l) or according to gender, but was positively correlated with age (P<0.0001 for both groups). OPG was statistically higher in 18 obese diabetic subjects compared with non-diabetics (P=0.03). After adjustment for age, no significant correlation was found between OPG and body mass index (BMI), waist, systolic and diastolic blood pressure, cholesterol, triglycerides, high density lipoprotein (HDL) cholesterol, leptin, and adiponectin in both the obese and non-obese subjects. However, OPG was positively correlated with homeostasis model assessment (HOMA) index and SGPT levels in obese subjects at baseline (r=0.295, r=0.20, P<0.05) and after adjustment for age (r=0.28, r=0.20, P<0.05). OPG was also significantly correlated with CRP; this correlation persisted after adjustment for age in obese subjects (r=0.30, P<0.01). In a multivariate analysis in the obese group, HOMA index and CRP were independent predictors of OPG while SGPT was not. Six months post-surgery, OPG did not change, despite a significant reduction in glucose, SGPT, cholesterol, triglycerides, CRP, and leptin values (P=0.02, P=0.006, P=0.007, P<0.001, P<0.001, P<0.001 respectively) and a significant increase in adiponectin and HDL values (P<0.001 for both variables).

Conclusion: Our results show that in obese subjects, OPG is not related to BMI. However, we describe new relationships between OPG and both HOMA index and CRP.

Citing Articles

Evaluation of the effects of obesity on orthodontic tooth movement.

Uzun M, Cesur M, Erdogan O Korean J Orthod. 2025; 55(1):3-14.

PMID: 39849962 PMC: 11788180. DOI: 10.4041/kjod24.001.


Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease.

Vachliotis I, Polyzos S Curr Obes Rep. 2023; 12(2):147-162.

PMID: 37208545 PMC: 10250495. DOI: 10.1007/s13679-023-00505-4.


Comparison of novel markers of metabolic complications and cardiovascular risk factors between obese non-diabetic and obese type 1 diabetic children and young adults.

Kacka A, Charemska A, Jarocka-Cyrta E, Glowinska-Olszewska B Front Endocrinol (Lausanne). 2022; 13:1036109.

PMID: 36578961 PMC: 9791985. DOI: 10.3389/fendo.2022.1036109.


Obesity and Bone Health: A Complex Relationship.

Pinar-Gutierrez A, Garcia-Fontana C, Garcia-Fontana B, Munoz-Torres M Int J Mol Sci. 2022; 23(15).

PMID: 35955431 PMC: 9368241. DOI: 10.3390/ijms23158303.


Identification of bone metabolism disorders in patients with Alström and Bardet-Biedl syndromes based on markers of bone turnover and mandibular atrophy.

Jeziorny K, Zmyslowska-Polakowska E, Wyka K, Pyziak-Skupien A, Borowiec M, Szadkowska A Bone Rep. 2022; 17:101600.

PMID: 35818441 PMC: 9270207. DOI: 10.1016/j.bonr.2022.101600.